Radiomics-Based Phenotyping for Treatment Optimization of HER2+ Breast Cancer A second Ignition Award is going to ... Launching a Multiplex BRCA1/RAD51C ddPCR Methylation Assay as a Clinical HRD Test ...

Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while ...

Previous work from other laboratories showed that PARP inhibitors are particularly toxic to cells with defects in the homologous recombination (HR) repair pathway, including breast and ... resistance ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

GE HealthCare partners with DeepHealth to enhance AI-driven imaging, improving breast cancer screening with SmartMammo. Collaboration aims to streamline workflows and improve early detection through ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.

Yale study reveals cultural influences in breast cancer surgery decisions, focusing on challenges faced by women of color post-mastectomy.

October is Breast Cancer Awareness Month — a worldwide campaign to raise awareness of the devastating disease and promote early detection through screenings. About one in eight women will be ...